Fesoterodine

• CAT Number: I015565
• CAS Number: 286930-02-7
• Molecular Formula: C₂₆H₃₇NO₃
• Molecular Weight: 411.58
• Purity: ≥95%
• Target: Neuronal Signaling
• IUPAC Name: [2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-(hydroxymethyl)phenyl] 2-methylpropanoate
• InChI: InChI=1S/C26H37NO3/c1-18(2)26(29)30-25-13-12-21(17-28)16-24(25)23(22-10-8-7-9-11-22)14-15-27(19(3)4)20(5)6/h7-13,16,18-20,23,28H,14-15,17H2,1-6H3/t23-/m1/s1
• InChIKey: DCCSDBARQIPTGU-HSZRJFAPSA-N
• SMILES: CC(C)C(=O)OC1=C(C=C(C=C1)CO)[C@H](CCN(C(C)C)C(C)C)C2=CC=CC=C2

Fesoterodine(CAT: I015565) is a muscarinic receptor antagonist used primarily in urological research to study overactive bladder (OAB) and urinary incontinence. It works by competitively inhibiting muscarinic receptors (M3 subtype) in the bladder’s detrusor muscle, reducing involuntary contractions and increasing bladder capacity. Fesoterodine is metabolized into its active form, 5-hydroxymethyl tolterodine (5-HMT), which effectively decreases urinary urgency and frequency. Researchers utilize Fesoterodine to explore bladder control mechanisms and develop therapies targeting muscarinic receptors for improved management of bladder dysfunction and related disorders.